These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6416243)

  • 1. Pathologic fracture due to severe osteomalacia following low-dose diphosphonate treatment of Paget's disease of bone.
    Evans RA; Dunstan CR; Hills E; Wong SY
    Aust N Z J Med; 1983 Jun; 13(3):277-9. PubMed ID: 6416243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).
    Eyres KS; Marshall P; McCloskey E; Douglas DL; Kanis JA
    Drug Saf; 1992; 7(2):162-5. PubMed ID: 1605902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
    Hoppé E; Masson C; Laffitte A; Chappard D; Audran M
    Morphologie; 2012 Aug; 96(313):40-3. PubMed ID: 23022200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.
    Boyce BF; Smith L; Fogelman I; Johnston E; Ralston S; Boyle IT
    Lancet; 1984 Apr; 1(8381):821-4. PubMed ID: 6143140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ethane-1 hydroxy-1, 1-diphosphonate (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone.
    Alexandre C; Meunier PJ; Edouard C; Khairi RA; Johnston CC
    Metab Bone Dis Relat Res; 1981; 3(4-5):309-15. PubMed ID: 6820112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of Paget's bone disease with sodium ethidronate.
    Fromm GA; Schajowicz F; Casco C; Ghiringhelli G; Mautalen CA
    Am J Med Sci; 1979; 277(1):29-37. PubMed ID: 106728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.
    Gibbs CJ; Aaron JE; Peacock M
    Br Med J (Clin Res Ed); 1986 May; 292(6530):1227-9. PubMed ID: 3085789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
    Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
    Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease.
    Labinson P; Taxel P
    Conn Med; 2007 May; 71(5):269-73. PubMed ID: 17526382
    [No Abstract]   [Full Text] [Related]  

  • 11. Diphosphonate therapy of paget's disease of bone.
    Canfield R; Rosner W; Skinner J; McWhorter J; Resnick L; Feldman F; Kammerman S; Ryan K; Kunigonis M; Bohne W
    J Clin Endocrinol Metab; 1977 Jan; 44(1):96-106. PubMed ID: 401827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphosphonate treatment of Paget's disease.
    Finerman GA; Gonick HC; Smith RK; Mayfield JM
    Clin Orthop Relat Res; 1976 Oct; (120):115-24. PubMed ID: 975646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
    D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
    Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
    Alexandre CM; Chapuy MC; Vignon E; Edouard C; Johnston CC; Meunier PJ
    Clin Orthop Relat Res; 1983 Apr; (174):193-205. PubMed ID: 6403270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
    Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
    Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term therapy of Paget's disease of bone with EHDP.
    Siris ES; Canfield RE; Jacobs TP; Baquiran DC
    Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Paget's disease of bone.
    Evans RA
    Med J Aust; 1983 Feb; 1(4):159-62. PubMed ID: 6405139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
    MacGowan JR; Pringle J; Morris VH; Stamp TC
    Skeletal Radiol; 2000 May; 29(5):279-82. PubMed ID: 10883448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.
    Basle MF; Rebel A; Renier JC; Audran M; Filmon R; Malkani K
    Clin Orthop Relat Res; 1984 Apr; (184):281-8. PubMed ID: 6423333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.